Lista de obras - Gernot Zollner - Dominio Público Uruguay

24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

artículo científico publicado en 2006

Abnormal hepatic sinusoidal bile acid transport: new insights into the pathogenesis of cholestasis?

artículo científico publicado en 2001

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

artículo científico publicado en 2003

Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.

artículo científico publicado en 2014

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1

scientific article published on 17 February 2019

CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice

artículo científico publicado en 2005

Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors.

artículo científico publicado en 2007

Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans

artículo científico publicado en 2012

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

artículo científico publicado en 2005

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids

artículo científico publicado en 2005

Cytokine-independent repression of rodent Ntcp in obstructive cholestasis

artículo científico publicado en 2005

Differential effects of norUDCA and UDCA in obstructive cholestasis in mice

artículo científico publicado en 2013

Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.

artículo científico publicado en 2010

Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver

artículo científico publicado en 2001

Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis

artículo científico publicado en 2007

Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: effect on pruritus and bile acid profile.

artículo científico publicado en 2004

Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts

artículo científico publicado en 2009

Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids

artículo científico publicado en 2005

Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.

artículo científico publicado en 2001

Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.

artículo científico publicado en 2015

Hepatic transport systems

artículo científico publicado en 2002

Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy

scientific article published on 25 August 2011

Hepatobiliary transporter expression in human hepatocellular carcinoma.

artículo científico publicado en 2005

Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress

artículo científico publicado en 2007

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

artículo científico publicado en 2001

Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice

artículo científico publicado en 2002

Ischemia and cholestasis: more than (just) the bile ducts!

scientific article published on 01 April 2008

Knotting of percutaneous endoscopic jejunostomy feeding tubes in two patients with Parkinson's disease and continuous Duodopa® treatment

artículo científico publicado en 2012

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

artículo científico publicado en 2006

Mechanisms of cholestasis

scientific article published on 01 February 2008

Molecular mechanisms of cholestasis.

artículo científico publicado en 2006

New insights into autoimmune cholangitis through animal models

artículo científico publicado en 2010

New molecular insights into the mechanisms of cholestasis.

artículo científico publicado en 2009

Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation

artículo científico publicado en 2008

Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.

scientific article published on 26 April 2010

Nuclear receptors as therapeutic targets in cholestatic liver diseases.

artículo científico publicado en 2009

Nuclear receptors in liver disease.

artículo científico publicado en 2011

Oncosis represents the main type of cell death in mouse models of cholestasis

artículo científico publicado en 2005

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

artículo científico publicado en 2004

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

artículo científico publicado en 2003

Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine

artículo científico publicado en 2003

Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver

artículo científico publicado en 2005

Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease

artículo científico publicado en 2010

Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

artículo científico publicado en 2006

Severe toxic hepatitis associated with dronedarone

artículo científico publicado en 2013

Signal Transducer and Activator of Transcription 3 Protects From Liver Injury and Fibrosis in a Mouse Model of Sclerosing Cholangitis

article

Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin

artículo científico publicado en 2004

Targeting nuclear bile acid receptors for liver disease

artículo científico publicado en 2011

Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents

artículo científico publicado en 2006

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

artículo científico publicado en 2002

Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients

artículo científico publicado en 2011

Lista de obras de Gernot Zollner

24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

Abnormal hepatic sinusoidal bile acid transport: new insights into the pathogenesis of cholestasis?

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.

Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1

CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice

Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors.

Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans

Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids

Cytokine-independent repression of rodent Ntcp in obstructive cholestasis

Differential effects of norUDCA and UDCA in obstructive cholestasis in mice

Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.

Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver

Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis

Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: effect on pruritus and bile acid profile.

Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts

Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids

Genetic disorders and molecular mechanisms in cholestatic liver disease--a clinical approach.

Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.

Hepatic transport systems

Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy

Hepatobiliary transporter expression in human hepatocellular carcinoma.

Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice

Ischemia and cholestasis: more than (just) the bile ducts!

Knotting of percutaneous endoscopic jejunostomy feeding tubes in two patients with Parkinson's disease and continuous Duodopa® treatment

Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.

Mechanisms of cholestasis

Molecular mechanisms of cholestasis.

New insights into autoimmune cholangitis through animal models

New molecular insights into the mechanisms of cholestasis.

Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation

Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis.

Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Nuclear receptors in liver disease.

Oncosis represents the main type of cell death in mouse models of cholestasis

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine

Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver

Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease

Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

Severe toxic hepatitis associated with dronedarone

Signal Transducer and Activator of Transcription 3 Protects From Liver Injury and Fibrosis in a Mouse Model of Sclerosing Cholangitis

Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin

Targeting nuclear bile acid receptors for liver disease

Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients